Regencell Bioscience Holdings Limited (RGC:NASDAQ) closed at $9.52 on October 15, 2026, up 17.39% on the day. The stock trades 86.2% below its 52-week high of $69.00 and 111.1% above its 52-week low of $4.51. Over the past year, it lost 56.8%. Regencell Bioscience Holdings Limited is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +13.74% | +44.82% | +61.55% | -71.14% | -56.77% |
In 252 trading sessions since October 14, 2025, RGC closed higher on 114 days (45%). Its best day was January 7, 2026 (+60.10%) and its worst was January 13, 2026 (-26.23%). The stock moved 10% or more in a single session 41 times. It opened at least 5% above the previous day's high 3 times.
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
Find more stocks like RGC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.